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Abstract
Background: Sharing drug injection equipment has been associated with the transmission of HCV among PWID
through blood contained in the cooker and cotton used to prepare and divide up the drug solution. While epidemiologists often subsume this practice under the sharing of “ancillary equipment,” more attention should be paid to the
fact that indirect sharing takes place within the process of joint drug acquisition and preparation.
Methods: We employed an ethnographic approach observing active PWID (N = 33) in four rural towns in Puerto Rico
in order to document drug sharing arrangements involved in “caballo”, as this practice is locally known. We explored
partners’ motivation to engage in drug sharing, as well as its social organization, social roles and existing norms.
Findings: Findings suggest that drug sharing, is one of the main drivers of the HCV epidemic in this population. Lack
of financial resources, drug packaging, drug of choice and the desire to avoid the painful effects of heroin withdrawal
motivates participants’ decision to partner with somebody else, sharing injection equipment—and risk—in the process. Roles are not fixed, changing not only according to caballo partners, but also, power dynamics.
Conclusion: In order to curb the HCV epidemic, harm reduction policies should recognize the particular sociocultural contexts in which people inject drugs and make decisions about risk. Avoiding sharing of injection equipment
within an arrangement between PWID to acquire and use drugs is more complex than assumed by harm reduction
interventions. Moving beyond individual risk behaviors, a risk environment approach suggest that poverty, and a strict
drug policy that encourage users to carry small amounts of illicit substances, and a lack of HCV treatment among
other factors, contribute to HCV transmission.
Keywords: PWID, HCV, Drug sharing, Risk environment, Harm reduction, Puerto rico
Background
While HCV-related deaths in the United States seem to
have declined recently [1], research suggests the existence
of an emerging hepatitis C virus (HCV) epidemic among
people who inject drugs (PWID) in non-urban areas [2],
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which is likely associated with the transition from oral
prescription opioid use to injection and often with the
transition from prescription opioids to heroin [3]. Rates
of HIV and HCV among PWID are on a divergent trajectory. HIV prevalence has been declining for almost a decade, while HCV has increased over the same period [4].
Nowhere in the United States are these trends more
prevalent than in Puerto Rico, a US territory, where
recent epidemiological data suggest epidemic levels of
HCV among PWID, with 89% prevalence in metropolitan
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San Juan and 78.4% in rural areas [5, 6]. In the US, HCV
prevalence among PWID ranks highest in Puerto Rico, at
a similar level as the worst cases in the global south [7, 8].
Epidemiological studies of HCV transmission routes
among PWID show that the virus can be transmitted not
only though blood contained in shared syringes but also
by sharing the cooker and cotton used to prepare the drug
solution [9–11]. Yet, epidemiologists often misunderstand the dynamics of HCV transmission among PWID,
subsuming the common use of a cooker, or a filtering cotton ball, as the shared use of “ancillary equipment” [12,
13]. As social scientists have noted, equipment sharing is
often a proxy for preparing and dividing drugs [14, 15].
Based on a study of PWID in Colorado, Koester (2005)
suggests that indirect sharing, which happens when powder drugs are diluted in water before been divided up in
a cooker with the help of a syringe, is an efficient way
of distributing drugs among injection partners. Using
the calibration on the syringe barrel allows participants
to compare the syringe contents’, effectively ensuring
an equitable distribution. This type of indirect sharing
which happens more often than direct syringe sharing,
when one syringe is shared from one user to another [16]
(Friedman et al. 1997) has been found to be a common
feature among PWID in a variety of social contexts [17–
24]. In a social network study of PWID in Brooklyn, New
York Curtis and colleagues (1995) found that indirect
sharing is extensively practiced within a network particular social networks, contributing to define a user position in it. Those that engage in drug sharing often, are the
“regulars” or insiders who are placed at the center of the
network, while those that do engage occasionally sometimes coming from other neighborhoods or sporadically
over the weekends, tend to occupy a peripheric position
[25]. A similar study by Zule with PWID in San Antonio
shows that participants drug sharing arrangements are
asymetric relationships, with the person that provides the
drug in a position to direct drug preparation and the person receiving the drug solution unable to avoid the indirect sharing of injection equipment [26].
A qualitative study of PWID in Tajikistan shows that
while few users report direct syringe sharing, joint drug
acquisition and preparation is common, particularly in
outdoor settings or if participants experience withdrawal
symptoms [27]. Another study in Viet Nam shows that
drug sharing practices are driven by heroin price and
accessibility as well as a punitive approach to drug use
that penalizes drug possession [28].
In a multi-year study of Puerto Rican PWID in New
York City and Bayamon, in San Juan found that, recent
migrants from the island exhibit a much higher frequency of indirect drug sharing than native users [29]. An
ethnographic study conducted among PWID in San Juan
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extends these observations by exploring the motivations
and social roles involved in drug sharing arrangements
[30]. Finlinson (2011) shows that the price and packaging of drugs and access to drug preparation materials
along with power differences among partners shape the
process by which drugs are prepared and injected. Other
ethnographic studies demonstrated that drug sharing is
facilitated by the type of heroin available. For example,
Bourgois documents how homeless PWID in San Francisco use “black tar,” a sticky variety of heroin, originating in Mexico, that is extremely hard to divide up without
preparing it, which, in turn, encourages the sharing of
injection equipment [31, 32].
Departing from epidemiological views that focus on
individual behaviors, these authors make a valuable
contribution to the understanding of HCV risk among
PWID by showing how particular social contexts, from
the ways in which drugs are acquired, to social roles, cultural norms, drug policies and power dynamics among
those involved in “caballo” shape HCV risk. These findings complicate traditional epidemiological views shaping harm reduction initiatives, suggesting that forms of
indirect sharing within the process of jointly acquiring
and using drugs, are not easily modified by knowledge
about HCV transmission, or the access to new injection
equipment alone. As critics have suggested, the focus on
individual behaviors at the expense of local social contexts in which PWID live and make decisions about risk,
might obscure how social, structural and environmental
contexts shape drug use and related harms [33–37].
Nested within a study of social networks and HIV/
HCV risk among PWID in rural Puerto Rico, we propose an ethnographically informed approach to “caballo”,
the joint acquisition and sharing of drugs, as a window
into the social production of an HCV epidemic among
PWID. While drug sharing arrangements among PWID
have been amply documented, an ethnographic study
of caballo in Puerto Rico will illuminate the social context behind the joint acquisition and use of drugs and its
related epidemiological risk.

Methods
This paper utilizes ethnographic data from PWID
recruited into a multi-phase study of social networks
and HIV/HCV risk in four rural towns in the mountainous area of central Puerto Rico. In the first phase of
this study we collected demographic and sociometric
data on PWID in rural Puerto Rico, as well as information on injection behaviors, particularly on the sharing
of syringes and injection equipment. In addition, rapid
blood testing for HIV and HCV were conducted using
INSTI Rapid HIV antibody tests (Biolytical Laboratories)
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and OraQuick HCV Rapid antibody tests (OraSure
Technologies).
It was during the administration of a National Health
Behavioral Survey (NHBS) questionnaire [38] that we
learned for the first time about “caballo”. Consistently, we
heard from participants that while they carried their own
syringe and avoided sharing it with others, they could
not avoid using the same cooker within the process of
drug sharing. Participants described the ways in which
they divided up the drug solution in the cooker, using a
backloading method to distribute it among partners. All
participants insisted that they “always used their own
cooker” during the preparation. Of course, since there are
two or more caballo partners and only one cooker available, this was not possible. After this phase of data collection, we were left with many questions about the social
organization and the meaning of drug sharing among this
population.
To explore these issues, we conducted an ethnographic
study with (N = 33) participants randomly recruited
from the first phase. During the participant observation,
each participant was followed -with their consent- for
up to two weeks, documenting practices related to joint
drug acquisition and use. Yet, our ethnographic observations were broadly constructed, focusing not only on
drug sharing practices, but in describing their everyday
lives and the strategies they used in order to afford their
drugs of choice. For example, we had ample opportunity
to observe participants’ hustling, in car washes, or guarding a parking lot, or begging at the entrance of banks
or dollar stores or other venues with heavy foot traffic. After partnering with El Punto en la Montana, the
only Syringe Exchange Provider in the area, we earned
participants’ trust and were allowed to join them at the
“chutin” a Spanglish deformation of shooting gallery. In
so doing, we were able to collect data on their drug sharing practices. We paid particular attention to the ways in
which caballo partners talked about acquiring and sharing drugs in an attempt to convey the norms or hidden
scripts regulating caballo arrangements. In addition, we
conducted in depth interviews to understand how PWID
in our study described the social practice of “caballo”, the
joint acquisition and later use of drugs. Some of the questions we posed were what is caballo, when do participants
do it and with whom. We used our initial observations to
iteratively refine our research questions. Since we had
observed during the course of the ethnographic data collection that sometimes arguments emerge during caballo,
we asked participants about potential problems or conflicts associated with this practice and we also inquired
about participants’ views on drug sharing related HCV
risk and their perceived ability to enact changes to prevent its transmission.
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One limitation of our data collection is that for security reasons, ethnographic observations were conducted
during the day and until dusk and only during working
days. Abandoned and dilapidated houses without electricity, shooting galleries are seldom used at night but are
more used early in the day -as soon as drug selling spots
are open- and on weekends when “regulars’ are joined
by more occasional users. Despite the limits imposed by
fieldwork dynamics we believe that our observations of
caballo and the social context in which it occurs were not
affected by these constraints.
Fieldnotes were transcribed while in-depth interviews
were transcribed and translated. All personal identifiers were removed. MAXQDA software was employed
to manage coding. Codes were developed to convey the
wide arrange of themes in the data set: caballo, drug
acquisition, motivations, social roles, norms and expectations and injection setting, among others. These codes
were then iteratively revised and re-organized until they
represented higher-level axial codes describing participants’ caballo experiences [39, 40]. Following Strauss’
grounded theory approach [41] (Strauss and Corbin
1998) the interpretation of the data emerged intuitively
without imposing a pre-existing theoretical framework.
The study received IRB approval through the (omitted due to blind review) and the (omitted due to blind
review). Participants provided written consent at the
study office prior to enrollment in the study and were
compensated for their time and travel expenses.

Findings
Participants’ sociodemographic background (Table 1).
Participants had a mean age of 44.15 years and the sample had a standard deviation of 9.2 years. The sample is
overwhelmingly male (87.8%) and heterosexual (96.97%).
Three-quarters were unemployed at the time, and almost
one-half lived in poverty and had completed high school
or a higher educational level. One in five were married or living together and the same number had been
homeless during the past year. Almost all participants
(90.91%) were currently covered by health insurance,
with a large majority having “La Reforma,” the local version of Medicare/Medicaid. Around one in six (15.15%)
had participated in a drug treatment program but only
one participant had enrolled during the past year. Participants had been injecting for a mean of 22.91 years
with a standard deviation of 10.54. Age at first injection
is 22.27 years with a standard deviation of 7.97. Almost
four out of ten reported injecting two or three times a
day while one in three injected four times or more a day.
While HIV prevalence in this population is extremely low
(3.03%), HCV prevalence reaches epidemic levels, with
almost nine out of ten study participants testing positive
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Table 1 Descriptive statistics
Mean/%
Age (years)

44.15

% Male

87.88%

SD
9.12

N
33
33

% Heterosexual

96.97%

33

% Unemployed

75.75%

33

% Experienced homelessness in past year

21.21%

33

% Graduate high school (or higher)

54.55%

33

% Married or living together as married

21.24%

33

% Annual income < $5000

51.52%

33

Average money spent on drugs daily

$41

% Currently covered by health insurance

90.91%

$24.45

33
33

% Ever participated in a drug treatment program

15.15%

Number of years injecting

20.91

10.54

33

Age at first injection

22.27

7.97

% Injected 4 or more times per day

30.30%

33
33
33

% Injected 2–3 times per day

39.39%

33

% Tested positive for HIV

3.03%

33

% Tested positive for HCV

84.84%

33

Last time you injected with someone did you…
Use a needle after someone else

7.14%

28

Use a sterile needle

84.62%

26

Use a cooker, water, or cotton that someone else had used

71.43%

28

Use drugs that had been divided with a syringe that someone else had used

32.14%

28

reactive for the virus (84.8%). Less than one in ten (7.14%)
declared having used a syringe after somebody else had
used it the last time they injected with somebody, and a
large majority (84.6%) admitted using a sterile syringe.
Almost three-quarters (71.43%) used a cooker, cotton, or
water that somebody had previously used, while one in
three (32.14%) divided drugs with a syringe that had been
previously used by somebody else.

Caballo and the social production of an HCV
epidemic
In rural Puerto Rico, two or more PWID often pool
funds necessary to acquire and later share drugs. Most
participants in our study have as a drug of choice heroin
“droga” and cocaine “perico”, “speedball”. Speedballs have
more heroin than cocaine, a usual way in which participants talk about their drug mix is by identifying it by the
ratio of heroin to cocaine. For example, they would say
“1–2” meaning one bag of cocaine and two of heroin.
Other users might prefer three bags of heroin and one of
cocaine “1–3”. In turn, this preference is also reflected in
drug sharing arrangements. The drugs are mixed together
in a cooker dissolved in water, and the resulting drug
solution is shared usually through backloading, removing
the plunger in a syringe and squirting the content using
the tip of the needle of a loaded syringe, before placing it

back. This practice is locally known as “caballo” (literally,
horse). Participants do not recall the origin of the name,
“caballo” but suggest that the same expression is used on
the island in situations where people pool resources to
acquire and later consume goods together, usually food
but also transportation. An ethnographic fieldnote taken
at the shooting gallery a few blocks away from where
our office was located, describes two study participants,
Pablito and Cesar Cayey engaging in a “caballo”:
Pablito and Cesar had bought their drugs of choice at
the one of the local “Puntos”, the drug selling spot, only
a few blocks away from the dilapidated house that served
as shooting gallery. They briefly discussed how the drugs
would be divided up agreeing that since they had contributed the same amount of money, each would receive
equal parts of the drug solution. However, since Pablito,
was helping Cesar inject because his partner was unable
to find his own veins, Pablito would be in charge of the
preparation.
The cooker, a small sized tin cup provided by the local
Syringe Exchange Provider, El Punto en la Montana and
a plastic water bottle were laid out on the cement floor by
Pablito, who was in charge of the preparation. The plastic
clear blue bag containing cocaine was opened and placed
carefully on the cooker along with the contents of three
colored metallic paper envelopes with heroin. Water
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from a plastic bottle was loaded into a syringe and then
discharged into the cooker. The content was then mixed
with the back of a syringe making sure it was completely
diluted. Although the cocaine is a white powder and the
heroin a light brown, grey or creamy color, when mixed
with water, the solution turned into a brown color.
Without heating—it is believed to “eat up” the drug
because when heated some of the content evaporates
leaving a more powerful concentration, but less quantityPablito skillfully “recogio” or loaded the preparation with
the help of a syringe with its needle inserted into a small
cotton ball no larger than the head of a match to filter any
impurities. With the syringe “full”, half of its content was
then “echado” distributed into Cesar’s syringe by removing the plunger on the back. After verifying that both
syringes had exactly the same amount by holding them
side by side, using the lines on the side of the syringes as
a guide, the plunger in Cesar’s syringe was placed back.
Both syringes were now, half full, having divided a loaded
syringe used to divide drugs up, in two equal parts.
Far from a ritual practice to strengthen a bond between
injection partners, caballo seems to be a consciously
made strategic decision to maximize drug access among
PWID. Drugs are jointly acquired and then divided up
among pooling partners. The most common arrangement is to distribute the drug solution according to the
monetary contributions of each member proportionally. Partners can share drugs at “brazo partido” a local
expression translated as half and half, or 50%-50%, if
they contributed equally, although it is possible that the
partner that contributes the most agrees to divide drugs
equally, particularly if they have a long-standing relationship with the caballo partner.
Josephine, a 34-year-old woman who started injecting
in her teens, provides a description of the advantages of
this practice: “Look, let’s suppose that I want to use two
and one [two bags of heroin and one bag of cocaine] and
that you have $5 and I have $10. So, I ask you, Julio, ‘Do
you have $5?’ ‘Yes,’ [you respond].[I say,] ‘Great! Let’s do
two and one, you put in those $5 for the perico [cocaine]
and I put [in for] the heroin.’ We put everything together
in the cooker, and then we divide it in the syringe, half
and half, and we get cured. That’s it.”
While most PWID in the study would prefer to avoid
caballo if they could, particularly, for high frequency
users, the economic demands make it extremely hard to
go during the day without partnering with another user
to acquire and use drugs. With a large proportion in
unemployment, receiving meager social security checks,
working at the lower levels of the local drug trade, or
engaging in side hustles, it becomes extremely difficult
for PWID in our area to secure the whole amount every
time they need to inject. Opioid users dread the painful
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effects of heroin withdrawal, or what they call “being
sick,” characterized by bodily pain and discomfort, nausea, coldness, shivers, and diarrhea that leave them “unable to function.” Only “la cura”, the cure, another dose
of heroin, would stop or prevent these symptoms form
occurring. Faced with limited resources to “get cured”
the user has to make a choice between partnering with
somebody in a caballo or going it alone and hustling until
they can afford the whole dose they need. Entering into a
caballo arrangement, enables them to feel normal again,
while they can keep hustling to get their next dose. While
the rewards of going alone might be higher because participants get their full dose, so are the associated costs
because users have to battle their withdrawal symptoms
while they come up with the money. And the longer it
takes for participants to secure the resources to afford
their dose, the worst their withdrawal symptoms become,
offering a powerful incentive to enter into a drug sharing
agreement with another user.
To avoid heroin withdrawal, if possible, caballo partners prefer to acquire their drug of choice in a Punto
close to where they can use it, without delay. But in relatively small rural locations, drug choices are restricted,
particularly in relation to package size. Locally, heroin
can be bought in bags of five or ten dollars and cocaine
comes in “cinquillos” fives, or $5, but if caballo partners
can get a hold on a car, they usually pool up $2 or $3 each
for gas and head to nearby Caguas o San Juan where bags
cost the same but are two or up to three times larger. This
drug packaging makes the trip worthwhile, even considering the gasoline costs and that time spent on the hour
round trip could have been used “revuleando”, hustling,
at home.
The frequency of caballo changes from participant to
participant; some engage in caballo almost every time
they use, while others do it less frequently. Since caballo
partners tend to inject smaller drug amounts, they also
need to engage in this practice more often. Speedball also
provides more opportunities to share drugs because one
partner might have cocaine but not heroin, while other
might be in the opposite situation, in this situation, one
solution is pooling resources and then dividing up the
drug solution.
PWID in our study declared that they prefer not to do
caballo for their first dose of the day, as it would significantly decrease the amount of heroin received and thus
stave off withdrawal symptoms for a shorter amount of
time. Walter, a 48-year-old user who injects two or three
times a day, explains this choice with the use of a metaphor: “It’s like pizza: if you eat two pieces you are going
to feel full but if you eat only one, or just a bite, you will
feel hungrier sooner.” However, here economic considerations play a role. If access to a sufficient dose to prevent
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the onset of withdrawal symptoms is not available, users
might resort to caballo early in the day. Those who have
been successful in securing their own first dose might
decide to engage in caballo later in the day in order to
maximize resources, and can afford to engage in the
practice more selectively. Caballo is also affected by a
particularly punitive version of the war on drugs adopted
by the Island since the 1980′s. Most of our study participants have been jailed at least once in their lifetime, often
for non-violent drug offences [42]. Having no more than
a few bags can lead to heavy prison sentences under the
“possession with intent” to distribute charges. To avoid
problems, PWID tend to carry small drug amounts with
them, which, in turn, encourages drug sharing.
Caballo can be structured along defined social roles,
with important epidemiological repercussions. A primary partner directs the preparation and distribution of
the drug solution, usually keeping the cooker and cotton
used to share drugs. The soaked filter and the drug residue left in the cooker can be later re-used adding a little
bit of water for another shot. Usually, this role is occupied by the user that contributed the most to the caballo.
These roles are not static, it is possible for one user to be
a primary partner in one caballo but engage in another
drug sharing arrangement later on, either with the same
partner or a different one, without being in charge of the
process.
In addition, partners might follow different strategies
while seeking to jointly acquire and use drugs. “Fixers” do
caballo with a limited number of trusted injection partners in their network, usually kin, or others with whom
they have close relationships, from school age friends,
to neighbors or those with whom they have shared
drugs extensively in the past. By minimizing the number of partners and routinizing sharing expectations, this
strategy ensures access to resources while limiting the
potential problems associated with doing caballo with
strangers. Other PWID take on the role of “maximizers,”
entering into caballo with as many partners as possible,
increasing their opportunities to access drugs by multiplying potential partners. Sometimes maximizers only
know their caballo partners because they have seen them
around, in Puntos, or shooting galleries, or because they
have done a caballo in the past. The downside is that this
choice also increases the potential problems associated
with the transaction—robbery, cheating, hoarding.
Yet, neither of these are fixed strategies. A PWID might
have been a maximizer but, over time, begun doing
caballo with a limited number of partners, and the opposite also happens. Jail, drug treatment, quitting drug use,
and migration can all affect a person’s social networks
and their ability to engage in caballo. Of course, this is
only an approximate typology, and some users are neither
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“fixers” nor “maximizers” but operate in between these
extremes.
Whether users might be primary partner or not, or
rely on a “fixer” or a “maximizer” strategy, they all seek
in their interactions some kind of fair play, adhering to
the norms that regulate drug sharing in the community.
Bebe, in his late 30 s, washes cars at a local gas station in
addition to taking turns as a drug dealer in the only drug
selling spot in town. He explains the need for reciprocity:
“I tend to avoid caballo, if I have all the money I need
for my dose I get the drug and I get your money and even
if you don’t have enough, I share with you because I know
what it is to be ‘sick.’ How much do you have, I would ask?
Four dollars [an insufficient amount for a 50/50 caballo].
Fine! Let’s go! and we share. But then I remember that in
other occasions it was me that had only four bucks and I
were really sick and he had his full dose and he decided
not to help me out, leaving me sick to fend for myself. I
still decided to help him but I tell him right away: ‘see,
before you told me you couldn’t help me because you had
enough for yourself and now you are desperate, see how
the world is round? Yesterday it was me [that needed]
and today it’s you. Come here, I’ll fix it!’”.
Caballo partners who consistently demand more than
their fair share are labeled “problematic” and tend to be
excluded. “Tricksters” are also avoided. According to participants, tricks are very common among PWID, such as
pocketing the money that participants have pooled to do
caballo. This is viewed very negatively, not only because
it causes a lack of trust among partners but also because
it deprives users of the “cure” they need, forcing them to
hustle for money again before they can have their dose.
Tampering with “bags,” for example by taking a cut, is
also negatively viewed but is judged less severely than
the first situation. Participants also worry about others
pulling a “water shoot,” a trick in which an injector uses
deception to substitute drugs with water. A similar and
more frequent trick involves placing not one but two cotton balls in the cooker, hiding the one used to filter the
drug under the finger holding the cooker, and leaving the
other with only a trace of drug for the other injector to
use. Personality issues and past disagreements also play
a role in selecting potential partners. Those users with
more social connections will be able to find more suitable partners for a caballo while being able to reject those
partners deemed less desirable. The reverse is also true:
those users with fewer social connections might not have
as many options. Caballo partnerships are often shaped
by asymmetric dynamics involving gender and other
forms of power disparities among prospective members.
These in turn affect risk taking and drug related harms.
Caballo partners try to manage HIV/HCV by serosorting,
but most assume that there is no point in asking about
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their partners’ HIV status, because “they will lie to you.”
Perhaps because they are in a more vulnerable position,
women tend to ask their injection partners about their
HCV status more often than men do. Women are also
more likely to avoid entering in a caballo with somebody
if they know the prospective partner has a positive status.

Discussion
This study outlines how the social practice of caballo
has contributed to the production of an HCV epidemic
among PWID in rural Puerto Rico. Results show that
84.84% tested positive reactive to HCV, a result that has
been confirmed by other epidemiological surveys in the
area [43]. PWID tend to avoid direct sharing of syringes;
only 7.14% reported having used a needle after somebody
else had employed it, and 84.62% used a sterile needle the
last time they used drugs with somebody. On the other
hand, participants often engaged in indirect sharing:
71.43% divided drugs with a cooker or cotton that had
been used by somebody else, and 32.14% divided drugs
with a syringe that had been used by somebody else.
These forms of indirect sharing are linked to the practice of caballo and the need to divide up jointly acquired
drugs, which in turn increases the risk of HCV among
this population. While PWID in our study tend to avoid
direct sharing, indirect sharing is driven by the mode of
drug acquisition, drug packaging and pricing, a reliance
on speedball, the need to avoid heroin withdrawal, and
a strict drug policy that encourage users to carry small
amounts of illicit substances, among other factors.
The finding that participants attempt to manage HIV/
HCV transmission risk during caballo by serosorting has
been replicated in other studies of PWID [44–46]. However, the epidemic levels of HCV in this population suggest that this strategy has serious limitations and that
individual behaviors alone are insufficient to curb HCV
transmission. Findings illustrate the need to understand
social epidemics such as HCV among PWID, leaving
behind individual-centered models prevalent in public
health. Decades of ethnographic studies with this population have shown that what appears to be the product of
individual behaviors is better comprehended as a result
of the particular social contexts in which PWID live and
make decisions about risk [47–56]. Moving beyond public health’s emphasis on individual behaviors, the notions
of “risk environment” [57] and “syndemics” [58] have
recently been used to analyze the interplay of micro-level
dynamics and larger structural forces in accounting for
risk outcomes. While both approaches share some features, Rhodes (2009) suggests that a risk-environment
approach—combining insights from political economy,
social epidemiology, and the sociology of health—can
be productive for understanding how the relationship
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between individuals and environment can produce drug
harms, thus contributing to a social science of “harm
reduction.” [59].
Our findings show that poverty and economic dispossession have been found to be an important driver of
indirect sharing among PWID. High frequency users
might spend $100 or even more a day, not an insignificant sum considering that Puerto Rico has a per capita
income more than half of the poorest US States like Missouri or Mississippi [60]. The same relationship between
poverty and drug sharing has been replicated in numerous studies [27, 31, 61]. In a study of homeless PWID in
San Francisco Bourgeois (1997) finds that if users cannot
afford their dose in full, indirect sharing allows users to
regulate their dose intake in order to minimize the risk
of experience heroin withdrawal, with some participants
using half or even a third of a bag each time. In turn,
using small doses encourages higher frequency of drug
injection, making drug sharing more likely.
Our findings have shown that roles within drug sharing arrangements are not fixed. This aspect has been
documented also by Finlinson [30] suggesting that roles
change within the process of acquiring and dividing up
drugs. According to this author, a primary partner in
charge of dividing up the drug solution using their own
equipment, might become a secondary partner receiving
a drug solution that has been divided using up somebody
else’s equipment in another caballo arrangement. These
practices facilitate the transmission of HCV within a
population, complicating harm reduction efforts.
One of the most distinctive features of indirect sharing in our study is that the drug preparation is usually
loaded from the cooker using a single syringe, and then
distributed to the injecting partners through backloading. While indirect sharing offers a fair method for equitable distribution [62], participants in our study do not
seem to favor drawing the drug solution directly from the
cooker, because of the perception that it makes it harder
to ensure an equal share of the drug. It is possible that
this preference might be driven by a lack of trust among
injection partners and that in different social contexts,
other ways of dividing up the drug solution might be
preferable. A study of Puerto Rican PWID in New York
and Puerto Rico show that PWID in New York City take
turns to draw the drug solution from the cooker while
those on the Island distributed it through backloading as
well as taking turns [63]. The fact that our findings correspond not to metropolitan San Juan, but rural Puerto
Rico might account for extensive use of backloading.
As other authors have shown, the joint acquisition and
use of drugs appear to be shaped by particular cultural
norms, which in turn are an adaptive response to a particular risk environment [64].
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Examining the social context in which PWID use
drugs and make decisions about risk is critical for the
successful adoption of harm reduction strategies to
reduce HCV [65–68]. While harm reduction policies
that emphasize the distribution of injection equipment are a valuable component in syringe exchange
programs, findings suggest that preventing the sharing drug preparation equipment while sharing drugs
might be more complex that behavioral health models suggests [69]. Indirect sharing occurs not because
PWID lack information about HCV risk or do not
possess knowledge about safe injection practices. This
perspective has been criticized for blaming the victim
[70] while obscuring the role of social and risk environments in shaping drug sharing arrangements [71, 72].
In addition, local implementation of effective harm
reduction recommendations regarding HCV transmission among PWID is hampered by larger political and
socio economic processes such as the Colonial status
of Puerto Rico that deprives the Island of the resources
it needs to tackle an HCV epidemic, while enacting an
aggressive version of the war on drugs and subsequent
incarceration that furthers the impact of HCV within
its population [73]. Furthermore, the subjection to US
patent laws and drug pricing ensures that despite the
fact that a new HCV treatment is available (in the form
of a three-month-long direct-acting antiviral regimen),
the cost of that treatment is approximately $50,000. In
the continental US, the cost of this treatment is covered by most private insurers or by Medicare/Medicaid; in Puerto Rico, few PWID have access to private
insurance, and HCV treatment is not covered by La
Reforma, a local version of Medicare/Medicaid for
HIV-negative individuals who constitute the majority
of the PWID population [74]. The extremely low HCV
coverage among PWID [75] continues to fuel the epidemic as HCV-negative users are more likely to enter
caballo arrangements with somebody infected by the
virus. Expanded HCV treatment coverage would not
only reduce the incidence of HCV among this population but also would contribute to provide certain measure of “herd immunity” protecting those that are HCV
negative [76].
Similarly, access to harm-reduction-based interventions such as medically assisted treatment and syringe
exchange provision have been shown to be protective
against HCV transmission [77–83]. Unfortunately, these
resources are severely lacking in Puerto Rico, particularly in rural areas [84]. A recent study showed that rural
PWID have less access to syringe exchange in rural areas
than those in urban settings, although both have had to
resort to acquiring syringes from drug stores, peers, and
drug dealers [85].
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Understanding the social factors behind the HCV
epidemic in Puerto Rico has a renewed urgency. As the
Island was starting to recover from the aftermath of Hurricane Maria in September 2017 it was hit by the arrival
of Covid-19, a pandemic with an epicenter in Wuhan
China that has currently stricken most of the world.
While the lasting effects of Covid-19 are not yet well
known, it is likely the pandemic will reinforce the devastating effects of hurricane Maria which furthered a
protracted economic crisis on the Island, while exposing
deep political corruption and mismanagement practices,
[86, 87] severely affecting the provision of health services
PWID rely on, like Medically Assisted Treatment and
Syringe Exchange Providers, leading the way to the worsening of an already existing HCV epidemic.
Increasingly, harm reduction programs will need to
consider the impact of large-scale natural disasters, or
pandemic events, and its effects on the risk environment
of PWID, already afflicted by severe forms of poverty,
social suffering, and structural violence [88].
One limitation of this study is that findings are based
on a sample that is overwhelmingly male. While this distribution mirrors not only the composition of the parent
study but also of other studies of PWID in Puerto Rico
that seem to be gendered, the relative lack of female participants raises questions about how gender dynamics
and power imbalances might shape drug sharing arrangements among PWID in rural Puerto Rico. More research
is needed to explore this issue. We believe that despite
this limitation, the study of the social organization of
drug sharing arrangements makes an important contribution to the understanding of HCV risk among this
population.

Conclusions
This study shows that drug sharing plays an important
role in the HCV transmission among PWID in rural
Puerto Rico. While participants avoided direct sharing of
syringes, they were forced to share the cooker and cotton
used to divide and inject the drug solution. Drug sharing
occurs not only within the joint acquisition and use of
injection drugs, but in a particular risk environment that
contributes to HCV risk. Poverty, drug packaging and
pricing, a reliance on speedball, the need to avoid heroin
withdrawal, and a strict drug policy that encourage users
to carry small amounts of illicit substances, among other
factors fuels the HCV transmission. This finding complicates harm reduction interventions based on the distribution of injection equipment or information about safe
injection practices alone, suggesting that preventing indirect sharing practices should consider the social context
in which PWID acquire and use drugs.
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